SPAC1527.03 Antibody

What is SPAC1527.03 and what are the key characteristics of antibodies targeting this protein?

SPAC1527.03 is a gene in Schizosaccharomyces pombe (fission yeast) that encodes a protein containing a La domain. The La domain is typically involved in RNA binding and metabolism, suggesting potential roles in RNA processing or stability. Antibodies targeting this protein are primarily polyclonal, generated using recombinant SPAC1527.03 protein from S. pombe strain 972/ATCC 24843 as the immunogen .

The standard format for commercially available SPAC1527.03 antibodies includes:

How should SPAC1527.03 antibody be stored and handled to maintain optimal activity?

Proper storage and handling are critical for maintaining antibody integrity and experimental reproducibility. For SPAC1527.03 antibody:

• Store at -20°C or -80°C for long-term preservation

• Avoid repeated freeze-thaw cycles, which can cause protein denaturation and loss of binding capacity

• For short-term storage (1-2 weeks), antibodies can be kept at 4°C

• When handling, maintain sterile conditions and use appropriate buffer systems

Following these guidelines helps prevent the common pitfalls of antibody degradation that can compromise experimental results.

What are the recommended validation protocols for confirming SPAC1527.03 antibody specificity?

Rigorous validation is essential before using any antibody in critical experiments. For SPAC1527.03 antibody, implement the following validation strategy:

• Western blot analysis: Compare wild-type S. pombe lysates with SPAC1527.03 knockout/knockdown samples to confirm absence of signal in the latter

• Pre-adsorption testing: Pre-incubate the antibody with purified antigen before immunostaining to verify signal elimination

• Multiple antibody comparison: If available, use antibodies from different sources/clones targeting different epitopes of SPAC1527.03

• Mass spectrometry: Confirm the identity of immunoprecipitated proteins using LC-MS/MS

Similar validation approaches are standard practice for research antibodies as demonstrated in studies of other target proteins .

What are optimal Western blotting conditions for detecting SPAC1527.03 protein?

Based on protocols used with similar yeast protein antibodies, the following Western blot conditions are recommended:

• Sample preparation:

  • Lyse yeast cells using glass bead disruption in buffer containing protease inhibitors

  • Use reducing conditions with DTT or β-mercaptoethanol

  • Heat samples at 95°C for 5 minutes

• Gel electrophoresis and transfer:

  • Use 10-12% SDS-PAGE gels

  • Transfer to PVDF membrane (preferred over nitrocellulose for this protein)

  • Apply wet transfer at 100V for 60-90 minutes

• Antibody incubation:

  • Block with 5% non-fat milk in TBST for 1 hour

  • Primary antibody dilution: 1:1000 (optimize as needed)

  • Incubate overnight at 4°C

  • Secondary antibody: HRP-conjugated anti-rabbit IgG (1:5000)

• Detection:

  • Use enhanced chemiluminescence (ECL) substrate

  • Expected band size: Approximately 28-30 kDa (verify with protein markers)

This methodological approach is modeled after successful protocols used with other yeast antibodies .

How can researchers address cross-reactivity when using SPAC1527.03 antibody in complex experimental systems?

Cross-reactivity is a significant concern with antibodies targeting La domain-containing proteins due to sequence conservation. Implement these strategies to mitigate cross-reactivity issues:

• Epitope mapping: Determine the specific epitope recognized by the antibody and assess its conservation across related proteins

• Sequential immunoprecipitation: Deplete cross-reactive proteins before isolating SPAC1527.03

• Competitive blocking: Use recombinant proteins containing conserved domains to selectively block cross-reactive antibodies

• Genetic controls: Include experiments with SPAC1527.03 knockout/knockdown strains as negative controls

Studies with RNA-binding antibodies have shown that cross-reactivity can be effectively managed through these approaches , ensuring experimental specificity even when working with conserved protein domains.

What methodologies are recommended for studying SPAC1527.03 protein interactions with RNA?

Given the La domain's role in RNA binding, researchers may want to investigate SPAC1527.03-RNA interactions:

• RNA immunoprecipitation (RIP):

  • Use SPAC1527.03 antibody to immunoprecipitate the protein along with bound RNAs

  • Isolate and sequence associated RNAs to identify binding partners

  • Include appropriate negative controls (IgG, non-RNA binding protein)

• Crosslinking immunoprecipitation (CLIP):

  • Employ UV crosslinking to capture direct RNA-protein interactions

  • Fragment RNA and immunoprecipitate with SPAC1527.03 antibody

  • Sequence recovered RNA fragments to map binding sites

• Electrophoretic mobility shift assay (EMSA):

  • Test binding of recombinant SPAC1527.03 to labeled RNA probes

  • Use the antibody for supershift assays to confirm specificity

These methodologies have proven effective in studies of La domain proteins and can be adapted to investigate SPAC1527.03's RNA interactions .

How should researchers interpret discrepancies between antibody-based detection methods when studying SPAC1527.03?

When faced with conflicting results across detection methods (e.g., Western blot vs. immunofluorescence), consider these interpretative frameworks:

• Post-translational modifications: Different antibodies may recognize distinct protein states

• Epitope masking: Protein-protein interactions may block antibody access in certain contexts

• Subcellular localization: The protein may exist in different compartments with varying accessibility

• Method-specific artifacts: Each technique has inherent limitations affecting detection

To resolve discrepancies:

• Employ multiple antibodies targeting different epitopes

• Use complementary detection methods (e.g., mass spectrometry)

• Validate with genetic approaches (tagged proteins, gene editing)

This approach is supported by studies showing that antibody-based detection can be influenced by multiple biological and technical factors .

How does working with yeast antibodies like SPAC1527.03 compare methodologically to mammalian antibodies?

Research with yeast antibodies presents distinct considerations compared to mammalian systems:

This comparative framework helps researchers adapt protocols when transitioning between yeast and mammalian systems, particularly for shared cellular processes involving RNA metabolism .

What are the implications of La domain evolutionary conservation for SPAC1527.03 antibody research?

The La domain shows significant evolutionary conservation across species, with important implications for antibody research:

• Phylogenetic analysis: The La domain structure is preserved from yeast to humans, suggesting fundamental roles in RNA metabolism

• Cross-species applications: May have limited potential for detecting homologous proteins in related species

• Functional conservation: Findings in S. pombe may translate to understanding La domain proteins in higher eukaryotes

• Epitope selection: Target unique regions outside the conserved domain for species-specific detection

Understanding this evolutionary context helps researchers interpret results and potentially translate findings across model systems, similar to approaches used with other conserved RNA-binding proteins .

How can emerging antibody technologies be applied to improve SPAC1527.03 detection and characterization?

Several cutting-edge approaches could enhance SPAC1527.03 research:

• Recombinant antibody fragments: Developing single-chain variable fragments (scFvs) or antigen-binding fragments (Fabs) for improved penetration in intact cells

• Nanobodies: Engineering smaller antibody derivatives that can access restricted epitopes

• Intrabodies: Expressing antibody fragments within cells to track native protein localization and interactions

• Proximity labeling: Combining antibodies with enzymes like BioID or APEX2 to identify neighboring proteins

These technologies have transformed research on mammalian proteins and could be adapted for yeast systems to provide new insights into SPAC1527.03 function .

What considerations should guide researchers designing multiplexed experiments involving SPAC1527.03 antibody?

When incorporating SPAC1527.03 antibody in multiplexed studies (multiple targets simultaneously):

• Antibody compatibility: Ensure primary antibodies are from different host species to avoid cross-detection

• Spectral separation: For fluorescence applications, select fluorophores with minimal spectral overlap

• Sequential detection: Consider sequential rather than simultaneous antibody application if cross-reactivity occurs

• Normalization controls: Include appropriate loading controls for accurate quantitative comparison

• Orthogonal validation: Complement antibody-based detection with non-antibody methods (e.g., RNA-seq for RNA-binding functions)

This methodological framework supports robust multiplexed experiments similar to approaches used in studies of other RNA-binding proteins .